Additionally, Ilieva et al. (86) reported the agomelatine-mediated reduction of frontal cortical and hippocampal levels of proinflammatory cytokines (TNF-α and IL-1β) in the Alzheimer's disease rat model. This evidence concerns the gene TNF and early-onset autosomal dominant Alzheimer disease.